跳至主要内容
临床试验/NCT01962740
NCT01962740终止不适用

Serial Evaluation of Drug-Eluting Stents Using OCT

North Texas Veterans Healthcare System2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
2
主要终点
Stent Strut Coverage

研究概览

简要总结

The study is proposed as a 48-patient randomized-controlled pilot study that will use Optical Coherence Tomography (OCT) imaging to compare stent strut coverage and malapposition of three second-generation Drug Eluting Stents (DES) [Xience EES (Abbott Vascular, Santa Clara, CA), Resolute Integrity ZES (Medtronic, Minneapolis, MN) and Promus Element EES (Boston Scientific, Natick, MA)] at 6 weeks post implantation.

Study Hypothesis is that the rates of stent strut coverage and malapposition of the Xience EES, Promus EES and will be similar to each other and improved (higher rates of stent strut coverage and lower rates of malapposition) compared to the Resolute ZES at 6 weeks post-implantation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than or equal to 18 years
  • Clinical need for percutaneous coronary intervention using either a Xience, Promus Element, or Resolute Integrity drug-eluting stent using optical coherence tomography optimization
  • Native coronary artery de novo lesion with ≥70% angiographic percent diameter stenosis by visual estimation
  • Target vessel reference diameter between 2.5 and 4.0 mm by visual estimate
  • Target lesion ≤28 mm in length by visual estimate
  • Agree to participate and provide informed consent

排除标准

  • 1.Presentation with acute ST-elevation myocardial infarction (defined as electrocardiographic (ECG) ST-elevation ≥ 2 mm in 2 or more contiguous ECG leads along with symptoms compatible with ischemia)

结局指标

主要结局

Stent Strut Coverage

时间窗: 6 weeks post-implantation

Stent Strut Malapposition

时间窗: 6 weeks post-implantation

次要结局

未报告次要终点

研究者

发起方
North Texas Veterans Healthcare System
申办方类型
Fed
责任方
Principal Investigator
主要研究者

Shuaib Abdullah, MD

Cardiologist; Assistant Professor, Division of Cardiology, Internal Medicine, UT Southwestern Medical School

North Texas Veterans Healthcare System

研究点 (2)

Loading locations...

相似试验